ALT SCHEDULE 13G/A: SEC filing

TCG Crossover entities

Filed with the SEC on · accession 0001193125-26-464037

ALT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. TCG Crossover entities filed an amended Schedule 13G reporting beneficial ownership of 5,000,000 shares of Altimmune common stock issuable upon exercise of common warrants (2.5% each), with Chen Yu deemed to beneficially own 10,000,000 shares (4.9%) across both funds. The stock moved -5.2% by the first close after the filing.

Summary of the filing

TCG Crossover entities filed an amended Schedule 13G reporting beneficial ownership of 5,000,000 shares of Altimmune common stock issuable upon exercise of common warrants (2.5% each), with Chen Yu deemed to beneficially own 10,000,000 shares (4.9%) across both funds. The filing is a passive investment disclosure with no change in ownership reported.

Key details

Shares of common stock issuable upon exercise of common warrants held by TCG Crossover Fund II, L.P.$5.0M
Shares of common stock issuable upon exercise of common warrants held by TCG Crossover Fund III, L.P.$5.0M
Aggregate shares deemed beneficially owned by Chen Yu$10.0M
IssuerAltimmune, Inc.
Reporting person / general partner of tcg crossover fund ii, l.p.TCG Crossover GP II, LLC
Reporting person / record holder of 5,000,000 warrant sharesTCG Crossover Fund II, L.P.
Reporting person / general partner of tcg crossover fund iii, l.p.TCG Crossover GP III, LLC
Reporting person / record holder of 5,000,000 warrant sharesTCG Crossover Fund III, L.P.
Sole managing member of tcg crossover gp ii, llc and tcg crossover gp iii, llcChen Yu

How ALT stock reacted

Close before

$1.65

Nov 13, 2026

First close after

-5.17%

$1.56

5 trading days

—

Since filing

-6.99%

$1.53

✦ Ask GOAX AI about this filing — what it means for ALT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALT?

Click here

Frequently asked questions

What did ALT file with the SEC on Nov 16, 2026?

ALT filed a SCHEDULE 13G/A (SEC filing). TCG Crossover entities filed an amended Schedule 13G reporting beneficial ownership of 5,000,000 shares of Altimmune common stock issuable upon exercise of common warrants (2.5% each), with Chen Yu deemed to beneficially own 10,000,000 shares (4.9%) across both funds. The filing is a passive investment disclosure with no change in ownership reported.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ALT stock react to this filing?

ALT closed at $1.65 before the filing and $1.56 on Nov 16, 2026 (-5.17%).

Other ALT SEC filings

Get alerts when ALT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days